Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Insulin Pumps Market offers comprehensive insights into the market landscape, customer intelligence, ...

Insulet (NASDAQ:PODD – Get Free Report) had its target price increased by investment analysts at TD Cowen from $264.00 to ...

Ozempic's ads were 57% more effective in driving consumer engagement on streaming TV than on linear TV during Q3.

Insulet develops, manufactures, and markets the Omnipod Insulin Management System for those with Type 2 diabetes. The system ...

Valued at a market cap of $18.5 billion, Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery ...

Insulet (NASDAQ: PODD) recently received a number of ratings updates from brokerages and research firms: 12/12/2024 – Insulet had its price target raised by analysts at JPMorgan Chase & Co. from $280.

In December, a Massachusetts corporation won the largest jury verdict ever awarded under the federal Defend Trade Secrets Act ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

Insulet Corporation’s PODD rapid progress with its strategic imperatives on Omnipod platform is poised to help it grow in the upcoming quarters. The largely untapped diabetes market also ...

One challenger to Medtronic is Insulet. It already markets its Omnipod, the world's first tubeless insulin management system, but has now released data for its own hybrid closed loop system.

The federal jury found that EOFlow and its CEO misappropriated four trade secrets related to Insulet’s wearable insulin patch pump, OmniPod, and determined the theft of three secrets to be willful and ...